The Growth of Clinical Trial Imaging Services in the Medical Industry: Market Trends and Forecasts | $1.8 Bn by 2027
The global clinical trial imaging services market was valued at $1.3 billion in 2019, and is expected to reach $1.8 billion by 2027, registering a CAGR of 5.6%
PORTLAND, OREGON, UNITED STATES, February 10, 2023 /EINPresswire.com/ -- ๐๐ก๐๐ญ ๐ข๐ฌ ๐ญ๐ก๐ ๐ฌ๐ข๐ณ๐ ๐จ๐ ๐ญ๐ก๐ ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ซ๐ข๐๐ฅ ๐๐ฆ๐๐ ๐ข๐ง๐ ๐๐๐ซ๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ?
According to the report published by Allied Market Research, the global Clinical Trial Imaging Services Market generated $1.31 billion in 2019, and is projected to garner $1.80 billion by 2027
Market Size By 2027 USD 1.80 Billion
Growth Rate CAGR of 5.6%
Forecast period 2020 โ 2027
Report Pages 270
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/9828
Clinical trial imaging services refer to the use of medical imaging techniques, such as X-rays, CT scans, MRIs, and PET scans, to gather data during clinical trials. The purpose of using these techniques in clinical trials is to provide a more comprehensive evaluation of a patient's condition and to monitor the effects of a particular treatment.
Imaging services play a crucial role in the development and approval of new drugs and medical devices. They help to determine the safety and efficacy of these products by providing visual evidence of their effects on the body. For example, imaging can be used to track the growth of tumors or the progression of a disease, to evaluate the effectiveness of a new drug or device, or to detect any adverse reactions to treatment.
The quality of imaging data is critical to the success of a clinical trial, and clinical trial imaging services are typically performed by highly trained and experienced radiologists and technologists. They use specialized equipment and techniques to produce high-quality images that accurately reflect the patient's condition and the effects of treatment.
In summary, clinical trial imaging services are an important part of the clinical trial process, helping to provide valuable information about the safety and efficacy of new drugs and medical devices.
๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐ญ๐ซ๐ข๐๐ฅ ๐ข๐ฆ๐๐ ๐ข๐ง๐ ๐ฌ๐๐ซ๐ฏ๐ข๐๐๐ฌ ๐๐๐ง ๐๐ ๐ฎ๐ฌ๐๐ ๐ข๐ง ๐ ๐ฏ๐๐ซ๐ข๐๐ญ๐ฒ ๐จ๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
Oncology: Imaging is used to evaluate the effectiveness of cancer treatments and to monitor the progression of the disease.
Neurology: Imaging is used to evaluate the effects of treatments for neurological conditions, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Cardiology: Imaging is used to evaluate the effectiveness of treatments for cardiovascular conditions, such as heart disease and hypertension.
Orthopedics: Imaging is used to evaluate the effectiveness of treatments for musculoskeletal conditions, such as arthritis and spinal injuries.
Gastroenterology: Imaging is used to evaluate the effectiveness of treatments for digestive conditions, such as irritable bowel syndrome and inflammatory bowel disease.
Dermatology: Imaging is used to evaluate the effectiveness of treatments for skin conditions, such as eczema and psoriasis.
Radiology: Imaging is used to evaluate the effectiveness of treatments for conditions that affect the bones, such as osteoporosis and fractures.
Pulmonology: Imaging is used to evaluate the effectiveness of treatments for respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD).
These are just a few examples of the many segments that use clinical trial imaging services. The specific imaging techniques used in each segment will vary depending on the condition being studied and the goals of the trial.
๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐๐ง๐๐ซ๐ข๐จ:
Owing to the Covid-19 pandemic, the focus of research and healthcare institutions shifted toward finding treatment for Covid-infected patients and there have been disruptions, cancellations, or rescheduling of many clinical trials.
There has been significant drop in demand for imaging in clinical trial services during the lockdown. On the other hand, the demand increased for R&D activities regarding development of therapeutics for Covid-19.
However, governments have introduced few relaxations in different regions during the post-lockdown. This is expected to raise the demand for these services and the market would recover soon.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/9828
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
By region, North America contributed to the highest market share, accounting for nearly two-fifths of the total market share in 2019, and is expected to maintain its dominant share throughout the forecast period. However, Asia-Pacific is projected to manifest the fastest CAGR of 7.4% from 2020 to 2027.
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, Rest of Asia-Pacific)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Leading players of the global clinical trial imaging services market analyzed in the research include Biospective Inc., BioClinica, Inc., ERT Clinical, Icon Plc, Calyx, Intrinsic Imaging LLC, IXICO plc, Micron Inc., Imaging Endpoints, Medpace Inc., Median Technologies, Pharmtrace, and ProScan Imaging.
Request Customization: https://www.alliedmarketresearch.com/request-for-customization/9828
Trending Reports in Healthcare Industry:
Body Contouring Devices Market
Elderly and Disabled Assistive Devices Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Analytics LLP
+ +1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
